Equities
Deep fundamental research across US, European, and emerging market equities — the same analytical depth applied at institutional desks, delivered to private clients.
Equity Research for Informed Investors
Explore company and market research across North America, Europe, and selected emerging markets with a focus on business quality, valuation, and risk.
We build full financial models for every company we cover — projecting income statements, balance sheets, and cash flows across base, bull, and bear scenarios. We derive intrinsic value using discounted cash flow analysis, comparable company analysis, and sum-of-the-parts frameworks, providing a robust, multi-dimensional view of what each business is worth relative to its current price.
Our research goes beyond numbers. We assess the quality of management, the strength of competitive moats, the capital allocation track record, and the long-term sustainability of the business model — factors that quantitative screens cannot capture but that often determine the difference between a good investment and a great one.
Deep Expertise Across All Major Sectors
Technology
From mega-cap platforms to high-growth software names — we cover the full technology spectrum with deep expertise in business model economics, TAM analysis, competitive positioning, and the AI infrastructure build-out that is reshaping the sector's economics at every level.
Financials
Banks, insurance companies, asset managers, and fintech disruptors across the US and Europe. We model net interest margin dynamics, credit quality cycles, regulatory capital requirements, and the structural impact of digital transformation on traditional financial services businesses.
Industrials & Energy
Capital-intensive businesses where understanding the cycle, cost structure, and capital allocation discipline of management is often more important than near-term earnings. We assess capex efficiency, return on invested capital, and the energy transition's impact on business model sustainability.
Healthcare & Life Sciences
Pharmaceutical pipelines, medical device innovators, and healthcare services businesses. We model drug development economics, patent cliff risk, and the regulatory pathway from Phase 2 to commercial launch — with particular expertise in biotech valuation under uncertainty.
Consumer
Both consumer staples and discretionary — assessing brand equity, pricing power, channel dynamics, and the impact of e-commerce disruption on traditional retail models. We pay particular attention to how consumer businesses perform across different phases of the economic cycle.
Emerging Markets
Selected coverage of emerging market equities — particularly in Asia, Latin America, and the Middle East — where valuation discounts to developed markets are significant but where political risk, currency risk, and corporate governance require additional analytical layers beyond standard DCF methodology.
What Goes Into Every Research Report
Financial Model
Three-statement financial model with explicit assumptions for revenue drivers, margin trajectory, working capital, capex, and capital structure. Bull, base, and bear scenarios with associated valuation ranges — giving you a probability-weighted view of the investment outcome rather than a single point estimate.
SEC Filing Analysis
Every 10-K, 10-Q, proxy statement, and 8-K filing is reviewed for the companies we cover. We specifically look for the disclosures buried in footnotes that analysts relying on consensus summaries will miss — changes in accounting policies, related-party transactions, and management compensation structures that reveal alignment of interest.
Competitive Analysis
We map every major competitor, assess relative market share, evaluate the sustainability of competitive advantages, and identify the most likely sources of disruption. We use Porter's Five Forces, network effect analysis, and switching cost assessment to evaluate the durability of each business's competitive moat.
Options Flow Confirmation
Before issuing a recommendation, we review options flow data to assess institutional positioning. Large unusual call activity — particularly in longer-dated options — can signal that sophisticated investors are positioning ahead of a catalyst our fundamental analysis has identified. Flow confirmation increases conviction and often improves timing.
Access Institutional Equity Research Today
Open an account to access our full equities research library, real-time screening tools, and AI-powered analysis across 400+ global stocks.
Open an Account View Live Markets